HardyCHROM CRE Culture Medium Recalled for Quality Control Failure
Hardy Diagnostics is recalling HardyCHROM CRE culture medium (Catalog No. G323) distributed across 22 US states and Puerto Rico. The product failed quality control testing due to breakthrough growth of Klebsiella pneumoniae.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of a medical device used in clinical microbiology testing. Failure to properly inhibit Klebsiella pneumoniae could lead to incorrect antimicrobial susceptibility results, potentially affecting clinical decision-making and patient care, which meets the threshold for Severe severity.
Plain-English summary
Hardy Diagnostics is recalling HardyCHROM CRE, a selective and differential culture medium used for antimicrobial susceptibility testing. The product (Catalog No. G323, UDI-DI 008165760257704) was distributed domestically to Arizona, California, Colorado, Florida, Georgia, Illinois, Maryland, Maine, Michigan, Minnesota, Missouri, North Carolina, Nebraska, Nevada, New York, Pennsylvania, Puerto Rico, Texas, Utah, Virginia, Wisconsin, and West Virginia.
The recall involves three lots: lot 653594P (manufactured March 6, 2025; expires May 15, 2025), lot 655101P (manufactured April 4, 2025; expires June 13, 2025), and lot 656816P (manufactured April 16, 2025; expires June 25, 2025). A total of 4300 units were distributed.
These lots failed incoming quality control testing and exhibited breakthrough growth of Klebsiella pneumoniae, a bacterium that should be inhibited by the selective medium. This quality failure could compromise the reliability of antimicrobial susceptibility testing results.
Healthcare facilities and laboratories that received this product should stop using the affected lots immediately and contact Hardy Diagnostics for replacement products or further guidance.
The recalled product
- Product
- HardyCHROM CRE, selective and differential culture medium for antimicrobial susceptibility testing, Product Catalog No. G323
- Manufacturer
- Hardy Diagnostics
- Affected units
- 4,300
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- UDI-DI 008165760257704 G323 lot 653594P: Manufactured on March 6
- 2025
- Expires on May 15
- 2025 G323 lot 655101P: Manufactured on April 4
- Expires on June 13
- 2025 G323 lot 656816P: Manufactured on April 16
- Expires on June 25
Distribution
Related recalls
Same manufacturer · Hardy Diagnostics
See all →- HighHardyDisk AST Cefiderocol 30µg for In Vitro Testing Recalled Due to Incorrect Cartridges
FDA (Devices) · 2026-08-12
- ModerateMedical microscope slide stainer recalled due to defective pump tubing
FDA (Devices) · 2021-06-16
- HighHardy Diagnostics Recalls Brain Heart Infusion Agar Plates Due to Contamination
FDA (Devices) · 2021-02-03
- HighHardy Diagnostics Recalls Viral Transport Media Due to Contamination Risk
FDA (Devices) · 2020-12-30
- LowHardy Diagnostics Recalls Strep B Carrot Broth Due to Incorrect Expiration Date
FDA (Devices) · 2020-11-18
Same hazard · quality control failure
See all →- High5-PLASMA Bivalirudin AMR Verification Kit Recalled Due to Stability Issues
FDA (Devices) · 2026-08-12
- HighEXENT Analyser marked plates as passed without performing quality control
FDA (Devices) · 2026-06-17
- HighPreeclampsia growth factor assay recalled over out-of-range quality control values
FDA (Devices) · 2026-04-15
- HighSusceptibility test cards recalled over false resistant antibiotic results
FDA (Devices) · 2026-02-11
- ModerateHeparin control material recalled after quality control results fell below acceptance range
FDA (Devices) · 2025-08-20